speb/financial-data huggingface dataset:
Financial ratios for AMTX — annual report dated 2022-12-31
Total revenue: 256513000
Gross profit: -5535000
Operating income: -34401000
Net income: -107758000
Capital expenditures: 39157000
Operating cash flow: -22866000
Depreciation & amortization: 5581000
Net tangible assets: -201854000
Owner earnings: -141334000
Buffett classification: The Gruesome
Stock price: 3.96
Shares outstanding: 70366477
Book value: -201854000
Market cap (USD): 278651248.92
Debt to equity: -1.2324105541629098
Current ratio: 0.20543491804578562
Quick ratio: 0.1526715827867831
Interest coverage ratio: -1.099249081322895
COGS to revenue (%): 102.15778537540008
R&D to revenue (%): 0.07017188212683179
SG&A to revenue (%): 11.183058948279424
Free cash flow (dilution-adjusted): -68433000
Buyback yield (%): 0
Retained earnings: -428985000
Inventory turnover: 56.25762129669386
Receivables turnover: 202.9375
Capitalized R&D asset: 238960
ROCI (R&D-adjusted, %): -28.814788413101905
FCF margin (%): -26.67818005325266
Rule of 40 score: -26.67818005325266
Financial ratios for AMTX — annual report dated 2023-12-31
Total revenue: 186717000
Gross profit: 2017000
Operating income: -37401000
Net income: -46420000
Capital expenditures: 33119000
Operating cash flow: 13825000
Depreciation & amortization: 7005000
Net tangible assets: -216977000
Owner earnings: -72534000
Buffett classification: The Gruesome
Stock price: 5.24
Shares outstanding: 70366477
Book value: -216977000
Market cap (USD): 368720339.48
Debt to equity: -1.3583052581610033
Current ratio: 0.43133583760916705
Quick ratio: 0.21458957921056063
Interest coverage ratio: -0.6414385676065034
COGS to revenue (%): 98.91975556590991
R&D to revenue (%): 0.08140662071477156
SG&A to revenue (%): 21.111093258782006
Free cash flow (dilution-adjusted): -26954000
Buyback yield (%): 8.136247661929495
Retained earnings: -475405000
Inventory turnover: 10.097862336668307
Receivables turnover: 21.628286806440403
Capitalized R&D asset: 301640
ROCI (R&D-adjusted, %): -23.468063749477146
Rosenberg metric: 41.955555555555556
FCF margin (%): -14.43575036017074
Revenue growth (%): -27.209537138468615
Rule of 40 score: -41.645287498639355
Financial ratios for AMTX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.3
Shares outstanding: 70366477
Market cap (USD): 161842897.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMTX — annual report dated 2024-12-31
Total revenue: 267640000
Gross profit: -580000
Operating income: -40416000
Net income: -87537000
Capital expenditures: 20254000
Operating cash flow: -32929000
Depreciation & amortization: 8387000
Net tangible assets: -263928000
Owner earnings: -99404000
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 70366477
Book value: -263928000
Market cap (USD): 189285823.13
Debt to equity: -1.2808834227516595
Current ratio: 0.3104578795287842
Quick ratio: 0.13373805290064458
Interest coverage ratio: -0.7646435598607537
COGS to revenue (%): 100.21670901210582
SG&A to revenue (%): 14.884172769391721
Free cash flow (dilution-adjusted): -61497000
Buyback yield (%): 0
Retained earnings: -562942000
Inventory turnover: 10.542410187878312
Receivables turnover: 18.97483161999291
Capitalized R&D asset: 161240
ROCI (R&D-adjusted, %): -35.089469199481
Rosenberg metric: -17.085526315789473
FCF margin (%): -22.977507099088328
Revenue growth (%): 43.33992084277275
Rule of 40 score: 20.36241374368442
Financial ratios for AMTX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 70366477
Market cap (USD): 189285823.13
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMTX — quarterly report dated 2025-03-31
Total revenue: 42886000
Gross profit: -5080000
Operating income: -15555000
Net income: -24529000
Capital expenditures: 0
Operating cash flow: 160000
Depreciation & amortization: 2369000
Net tangible assets: -280695000
Owner earnings: -22160000
Buffett classification: The Gruesome
Stock price: 1.74
Shares outstanding: 70366477
Book value: -280695000
Market cap (USD): 122437669.98
Debt to equity: -1.1980655159514775
Current ratio: 0.16318921426566857
Quick ratio: 0.03186121499876862
Interest coverage ratio: -1.1698127397157254
COGS to revenue (%): 111.84535745931072
SG&A to revenue (%): 24.425220351629903
Free cash flow (dilution-adjusted): -3973000
Buyback yield (%): 1.796832625416154
Retained earnings: -587471000
Inventory turnover: 2.0918447448757087
Receivables turnover: 41.11792905081496
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.902955077521092
FCF margin (%): -9.264095509023925
Rule of 40 score: -9.264095509023925
Financial ratios for AMTX — quarterly report dated 2025-06-30
Total revenue: 52243000
Gross profit: -3355000
Operating income: -10674000
Net income: -23395000
Capital expenditures: 3525000
Operating cash flow: -5737000
Depreciation & amortization: 2362000
Net tangible assets: -289255000
Owner earnings: -24558000
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 70366477
Book value: -289255000
Market cap (USD): 174508862.96
Debt to equity: -1.1900641302656825
Current ratio: 0.06239302699059104
Quick ratio: 0.023965060401892356
Interest coverage ratio: -0.8045526494309189
COGS to revenue (%): 106.4219129835576
SG&A to revenue (%): 14.009532377543401
Free cash flow (dilution-adjusted): -10645000
Buyback yield (%): 0
Retained earnings: -610866000
Inventory turnover: 4.4942203540538355
Receivables turnover: 19.356428306780288
Capitalized R&D asset: 0
FCF margin (%): -20.375935532032997
Revenue growth (%): 21.818309005269786
Rule of 40 score: 1.4423734732367883
Financial ratios for AMTX — quarterly report dated 2025-09-30
Total revenue: 59190000
Gross profit: -58000
Operating income: -8508000
Net income: -23747000
Capital expenditures: 4091000
Operating cash flow: 3068000
Depreciation & amortization: 2337000
Net tangible assets: -304852000
Owner earnings: -25501000
Buffett classification: The Gruesome
Stock price: 2.25
Shares outstanding: 70366477
Book value: -304852000
Market cap (USD): 158324573.25
Debt to equity: -1.1595889152769212
Current ratio: 0.04529873458273266
Quick ratio: 0.03138642552385945
Interest coverage ratio: -0.6110751993104935
COGS to revenue (%): 100.09798952525763
SG&A to revenue (%): 14.276060145294814
Free cash flow (dilution-adjusted): -2308000
Buyback yield (%): 0
Retained earnings: -634613000
Inventory turnover: 12.402763240527527
Receivables turnover: 35.89448150394178
Capitalized R&D asset: 0
FCF margin (%): -3.8993073154249025
Revenue growth (%): 13.297475259843425
Rule of 40 score: 9.398167944418523
Financial ratios for AMTX — annual report dated 2025-12-31
Total revenue: 207981000
Gross profit: -768000
Operating income: -37218000
Net income: -77001000
Capital expenditures: 26002000
Operating cash flow: 3263000
Depreciation & amortization: 9625000
Net tangible assets: -306831000
Owner earnings: -93378000
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 70366477
Book value: -306831000
Market cap (USD): 97809403.02999999
Debt to equity: -1.244215871277674
Current ratio: 0.07238093185870742
Quick ratio: 0.04106308820281314
Interest coverage ratio: -0.6837647664014992
COGS to revenue (%): 100.3692645001226
SG&A to revenue (%): 17.52563936128781
Free cash flow (dilution-adjusted): -28510000
Buyback yield (%): 0
Retained earnings: -639943000
Inventory turnover: 17.953814397523008
Receivables turnover: 429.71280991735534
Capitalized R&D asset: 50160
FCF margin (%): -13.707982940749394
Revenue growth (%): -22.29076371244956
Rule of 40 score: -35.99874665319896
Financial ratios for AMTX — quarterly report dated 2025-12-31
Total revenue: 53662000
Gross profit: 7725000
Operating income: -2481000
Net income: -5330000
Capital expenditures: 16561000
Operating cash flow: 5772000
Depreciation & amortization: 2557000
Net tangible assets: -306831000
Owner earnings: -19334000
Buffett classification: The Gruesome
Stock price: 1.39
Shares outstanding: 70366477
Book value: -306831000
Market cap (USD): 97809403.02999999
Debt to equity: -1.244215871277674
Current ratio: 0.07238093185870742
Quick ratio: 0.04106308820281314
Interest coverage ratio: -0.17792598967297762
COGS to revenue (%): 85.60433826543922
SG&A to revenue (%): 19.019045134359512
Free cash flow (dilution-adjusted): -11584000
Buyback yield (%): 0
Retained earnings: -639943000
Inventory turnover: 3.9508901694332157
Receivables turnover: 110.87190082644628
Capitalized R&D asset: 0
FCF margin (%): -21.58697029555365
Revenue growth (%): -9.3394154417976
Rule of 40 score: -30.926385737351254
Financial ratios for AUNA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.91
Shares outstanding: 30138747
Market cap (USD): 208258741.77
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUNA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.86
Shares outstanding: 30138747
Market cap (USD): 206751804.42000002
Buyback yield (%): 0
Retained earnings: -284930208.3333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUNA — annual report dated 2024-12-31
Total revenue: 4568866666.666667
Gross profit: 1797180208.3333335
Operating income: 777275000
Net income: 129122916.66666667
Capital expenditures: 94420833.33333334
Operating cash flow: 696352083.3333334
Depreciation & amortization: 228277083.33333334
Net tangible assets: -1228825000
Owner earnings: 262979166.66666666
Return on net tangible assets (%): -21.400863968967645
Capex to operating income (%): 12.147674032142207
Buffett classification: The Great
Stock price: 6.86
P/E ratio: 1.6012014734280966
Shares outstanding: 30138747
Book value: 1690562500
P/B ratio: 0.12229764023512885
Market cap (USD): 206751804.42000002
Debt to equity: 2.3215041837652657
Current ratio: 0.8759008366426341
Quick ratio: 0.8019966328668183
Effective tax rate (%): 32.549774999047756
Interest coverage ratio: 1.5413744595674885
COGS to revenue (%): 60.66463875067486
SG&A to revenue (%): 19.620771197817106
Free cash flow (dilution-adjusted): 539067708.3333334
Buyback yield (%): 0
Retained earnings: -284930208.3333334
Inventory turnover: 18.50824267549595
Receivables turnover: 4.559908346727159
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.530074803644085
FCF margin (%): 11.798718318182482
Revenue growth (%): 6.090780815948386
Rule of 40 score: 17.88949913413087
Financial ratios for AUNA — quarterly report dated 2025-03-31
Total revenue: 1132466304.347826
Gross profit: 414805434.7826087
Operating income: 158220652.17391303
Net income: 41264130.43478261
Capital expenditures: 34630434.782608695
Operating cash flow: 115233695.6521739
Depreciation & amortization: 58026086.956521735
Net tangible assets: -1225009782.6086955
Owner earnings: 64659782.60869565
Return on net tangible assets (%): -5.278307449186298
Capex to operating income (%): 21.88743018486841
Buffett classification: The Great
Stock price: 7.11
P/E ratio: 1.2982612799067514
Shares outstanding: 30138747
Book value: 1816357608.695652
P/B ratio: 0.11797593719657534
Market cap (USD): 214286491.17000002
Debt to equity: 2.235170841788601
Current ratio: 0.8348801543170621
Quick ratio: 0.7757840464719076
Effective tax rate (%): 38.29863312041867
Interest coverage ratio: 1.1812398055652484
COGS to revenue (%): 63.37149872008862
SG&A to revenue (%): 22.65716707186796
Free cash flow (dilution-adjusted): 59259782.60869565
Buyback yield (%): 0
Retained earnings: -258811956.52173913
Inventory turnover: 5.486567114568012
Receivables turnover: 1.0238301368193794
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8915488895298527
FCF margin (%): 5.232807579455766
Rule of 40 score: 5.232807579455766
Financial ratios for AUNA — quarterly report dated 2025-06-30
Total revenue: 1286985882.3529413
Gross profit: 511056470.5882353
Operating income: 202349411.7647059
Net income: 98849411.76470588
Capital expenditures: 18852941.17647059
Operating cash flow: 170832941.1764706
Depreciation & amortization: 65062352.941176474
Net tangible assets: -1267340000
Owner earnings: 145058823.5294118
Return on net tangible assets (%): -11.445927969559218
Capex to operating income (%): 9.317022971330895
Buffett classification: The Great
Stock price: 6.2
P/E ratio: 1.3336343401693127
Shares outstanding: 30138747
Book value: 2112957647.0588236
P/B ratio: 0.08843538897246904
Market cap (USD): 186860231.4
Debt to equity: 2.0614048665544926
Current ratio: 0.9113345584153197
Quick ratio: 0.8375225718434084
Effective tax rate (%): 36.48266581999062
Interest coverage ratio: 1.7290474993717015
COGS to revenue (%): 60.29043693518279
SG&A to revenue (%): 20.826957286427568
Free cash flow (dilution-adjusted): 128185882.35294119
Buyback yield (%): 0
Retained earnings: -183677647.05882353
Inventory turnover: 4.747009457455844
Receivables turnover: 1.0749236751109623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2545577849244736
FCF margin (%): 9.960162276107056
Revenue growth (%): 13.644518818076559
Rule of 40 score: 23.604681094183615
Financial ratios for AUNA — quarterly report dated 2025-09-30
Total revenue: 1418823529.4117649
Gross profit: 492941176.47058827
Operating income: 188235294.11764705
Net income: 62352941.17647059
Capital expenditures: 14252941.176470589
Operating cash flow: 222090588.23529413
Depreciation & amortization: 67427058.8235294
Net tangible assets: -1260967058.8235295
Owner earnings: 115527058.8235294
Return on net tangible assets (%): -9.1617824601473
Capex to operating income (%): 7.571875
Buffett classification: The Great
Stock price: 6.72
P/E ratio: 1.0003254685068963
Shares outstanding: 30138747
Book value: 2135294117.6470594
P/B ratio: 0.09484987485619832
Market cap (USD): 202532379.84
Debt to equity: 2.013774104683195
Current ratio: 0.8967229394240317
Quick ratio: 0.8227408142999008
Effective tax rate (%): 45.36082474226804
Interest coverage ratio: 1.379310344827586
COGS to revenue (%): 57.87728026533996
SG&A to revenue (%): 21.4759535655058
Free cash flow (dilution-adjusted): 182968235.29411766
Buyback yield (%): 0
Inventory turnover: 4.684563758389261
Receivables turnover: 1.1208178438661711
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.037205770690964
FCF margin (%): 12.895771144278607
Revenue growth (%): 10.24390779002101
Rule of 40 score: 23.139678934299617
Financial ratios for AUNA — annual report dated 2025-12-31
Total revenue: 5159174117.6470585
Gross profit: 1957309411.764706
Operating income: 742674117.6470588
Net income: 130470588.23529412
Capital expenditures: 93531764.70588236
Operating cash flow: 779415294.117647
Depreciation & amortization: 261683529.4117647
Net tangible assets: -1298342352.9411764
Owner earnings: 298622352.9411765
Return on net tangible assets (%): -23.0002781827688
Capex to operating income (%): 12.593917370139385
Buffett classification: The Great
Stock price: 4.92
P/E ratio: 1.1365215505320108
Shares outstanding: 30138747
Book value: 2078065882.3529415
P/B ratio: 0.0713560799487759
Market cap (USD): 148282635.24
Debt to equity: 2.06981435225968
Current ratio: 1.106453160897132
Quick ratio: 1.0075994697346873
Effective tax rate (%): 44.34211781002043
Interest coverage ratio: 1.4513123984118335
COGS to revenue (%): 62.061574834823084
SG&A to revenue (%): 20.456443324946218
Free cash flow (dilution-adjusted): 596035294.1176472
Buyback yield (%): 0
Retained earnings: -226605882.3529412
Inventory turnover: 16.514672508161507
Receivables turnover: 4.20534296388925
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.210724823094548
FCF margin (%): 11.55292069090858
Revenue growth (%): 12.920216194688502
Rule of 40 score: 24.473136885597082
Financial ratios for AUNA — quarterly report dated 2025-12-31
Total revenue: 1329762352.9411764
Gross profit: 504368235.2941177
Operating income: 180321176.47058824
Net income: -75411764.70588236
Capital expenditures: 22943529.411764707
Operating cash flow: 261768235.29411766
Depreciation & amortization: 66389411.76470588
Net tangible assets: -1298342352.9411764
Owner earnings: -31965882.35294118
Capex to operating income (%): 12.723702152368649
Buffett classification: The Great
Stock price: 4.92
P/E ratio: 1.1670769633125222
Shares outstanding: 30138747
Book value: 2078065882.3529415
P/B ratio: 0.0713560799487759
Market cap (USD): 148282635.24
Debt to equity: 2.06981435225968
Current ratio: 1.106453160897132
Quick ratio: 1.0075994697346873
Interest coverage ratio: 2.017626074479708
COGS to revenue (%): 62.24774351542691
SG&A to revenue (%): 14.048507561722662
Free cash flow (dilution-adjusted): 220741176.47058824
Buyback yield (%): 0
Retained earnings: -226605882.3529412
Inventory turnover: 4.269378269153752
Receivables turnover: 1.0839151048339457
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.72196248819476
FCF margin (%): 16.600047067233596
Revenue growth (%): -6.277114427860711
Rule of 40 score: 10.322932639372885
Financial ratios for AVH.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.9323308270676693
Shares outstanding: 153883445
Market cap (USD): 605120614.5488722
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVH.AX — annual report dated 2022-12-31
Total revenue: 34421000
Gross profit: 28380000
Operating income: -27505000
Net income: -26665000
Capital expenditures: 452000
Operating cash flow: -19090000
Depreciation & amortization: 568000
Net tangible assets: 84275000
Owner earnings: -26549000
Return on net tangible assets (%): -31.502818154850193
Buffett classification: The Gruesome
Stock price: 1.3243243243243243
Shares outstanding: 153883445
Book value: 84740000
P/B ratio: 2.404904287518578
Market cap (USD): 203791589.32432434
Debt to equity: 0.010833136653292424
Current ratio: 8.178995604601141
Quick ratio: 7.980267464696531
Interest coverage ratio: -1719.0625
COGS to revenue (%): 17.55033264576857
R&D to revenue (%): 40.257401005200315
SG&A to revenue (%): 131.44010923564102
Free cash flow (dilution-adjusted): -26613000
Buyback yield (%): 0
Retained earnings: -262588000
Inventory turnover: 2.8428235294117647
Receivables turnover: 6.939717741935484
Capitalized R&D asset: 13857000
ROCI (R&D-adjusted, %): -18.009819773632525
FCF margin (%): -77.31617326631998
Rule of 40 score: -77.31617326631998
Financial ratios for AVH.AX — annual report dated 2023-12-31
Total revenue: 50143000
Gross profit: 42363000
Operating income: -42655000
Net income: -35381000
Capital expenditures: 1381000
Operating cash flow: -38011000
Depreciation & amortization: 632000
Net tangible assets: 48569000
Owner earnings: -36130000
Return on net tangible assets (%): -74.38901356832548
Buffett classification: The Gruesome
Stock price: 2.9383561643835616
Shares outstanding: 153883445
Book value: 49056000
P/B ratio: 9.217310200838403
Market cap (USD): 452164369.2123288
Debt to equity: 0.8645017938682322
Current ratio: 7.879839381771347
Quick ratio: 7.455867868777938
Interest coverage ratio: -37.31846019247594
COGS to revenue (%): 15.5156253116088
R&D to revenue (%): 41.52324352352272
SG&A to revenue (%): 130.875695510839
Free cash flow (dilution-adjusted): -47842000
Buyback yield (%): 0
Retained earnings: -297969000
Inventory turnover: 1.3902787705503932
Receivables turnover: 6.330387577326095
Capitalized R&D asset: 30105190
ROCI (R&D-adjusted, %): -25.977692013534853
Rosenberg metric: 1.0090928772461571
FCF margin (%): -95.41112418483138
Revenue growth (%): 45.675605008570344
Rule of 40 score: -49.735519176261036
Financial ratios for AVH.AX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.0827586206896553
Shares outstanding: 153883445
Market cap (USD): 320502071.65517247
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVH.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.639751552795031
Shares outstanding: 153883445
Market cap (USD): 406214062.88819873
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVH.AX — annual report dated 2024-12-31
Total revenue: 64251000
Gross profit: 55157000
Operating income: -56593000
Net income: -61845000
Capital expenditures: 9171000
Operating cash flow: -48939000
Depreciation & amortization: 1126000
Net tangible assets: -1071000
Owner earnings: -69890000
Buffett classification: The Gruesome
Stock price: 2.639751552795031
Shares outstanding: 153883445
Book value: 4499000
P/B ratio: 90.28985616541426
Market cap (USD): 406214062.88819873
Debt to equity: 10.221160257835075
Current ratio: 2.8276614743526145
Quick ratio: 2.467060224228594
Interest coverage ratio: -10.556426039917925
COGS to revenue (%): 14.153865309489348
R&D to revenue (%): 31.688222751396864
SG&A to revenue (%): 142.23903129912375
Free cash flow (dilution-adjusted): -71768000
Buyback yield (%): 0
Retained earnings: -359814000
Inventory turnover: 1.251066171412849
Receivables turnover: 5.370809997492268
Capitalized R&D asset: 38882880
ROCI (R&D-adjusted, %): -55.44624582012169
Rosenberg metric: 0.6144757696556361
FCF margin (%): -111.69942880266454
Revenue growth (%): 28.135532377400637
Rule of 40 score: -83.5638964252639
Financial ratios for AVH.AX — quarterly report dated 2025-03-31
Total revenue: 18514000
Gross profit: 15681000
Operating income: -11827000
Net income: -13859000
Capital expenditures: 221000
Operating cash flow: -10309000
Depreciation & amortization: 521000
Net tangible assets: -10018000
Owner earnings: -13559000
Buffett classification: The Gruesome
Stock price: 1.7106918238993711
Shares outstanding: 153883445
Book value: -4571000
Market cap (USD): 263247151.19496855
Debt to equity: -9.641872675563334
Current ratio: 2.0895190799790906
Quick ratio: 1.7238194807457745
Interest coverage ratio: -9.592051905920519
COGS to revenue (%): 15.301933671815924
R&D to revenue (%): 33.941881819163875
SG&A to revenue (%): 114.63757156746246
Free cash flow (dilution-adjusted): -13237000
Buyback yield (%): 0
Retained earnings: -373673000
Inventory turnover: 0.33746277546158426
Receivables turnover: 1.5240368784985183
Capitalized R&D asset: 6284000
ROCI (R&D-adjusted, %): -14.442301389204045
FCF margin (%): -71.49724532785999
Rule of 40 score: -71.49724532785999
Financial ratios for AVH.AX — quarterly report dated 2025-06-30
Total revenue: 18418000
Gross profit: 14949000
Operating income: -11148000
Net income: -9920000
Capital expenditures: 524000
Operating cash flow: -10229000
Depreciation & amortization: 552000
Net tangible assets: -18200000
Owner earnings: -9892000
Buffett classification: The Gruesome
Stock price: 1.1241830065359477
Shares outstanding: 153883445
Book value: -12892000
Market cap (USD): 172993153.85620916
Debt to equity: -3.4585789636984177
Current ratio: 0.5791029040605732
Quick ratio: 0.4587233634708156
Interest coverage ratio: -8.904153354632587
COGS to revenue (%): 18.834835487023565
R&D to revenue (%): 27.782603974372893
SG&A to revenue (%): 113.91030513627973
Free cash flow (dilution-adjusted): -13428000
Buyback yield (%): 0
Retained earnings: -383593000
Inventory turnover: 0.46032377919320594
Receivables turnover: 1.5805372007208445
Capitalized R&D asset: 9327280
ROCI (R&D-adjusted, %): -202.32078277714672
Rosenberg metric: -0.11648631444939529
FCF margin (%): -72.90693886415464
Revenue growth (%): -0.5185265204709949
Rule of 40 score: -73.42546538462564
Financial ratios for AVH.AX — quarterly report dated 2025-09-30
Total revenue: 17062000
Gross profit: 13875000
Operating income: -9153000
Net income: -13187000
Capital expenditures: 934000
Operating cash flow: -5219000
Depreciation & amortization: 574000
Net tangible assets: -11870000
Owner earnings: -13547000
Buffett classification: The Gruesome
Stock price: 1.0657894736842106
Shares outstanding: 153883445
Book value: -6666000
Market cap (USD): 164007355.85526317
Debt to equity: -6.716621662166217
Current ratio: 0.6690333327942294
Quick ratio: 0.5519399653895295
Interest coverage ratio: -7.218454258675079
COGS to revenue (%): 18.67893564646583
R&D to revenue (%): 21.96694408627359
SG&A to revenue (%): 112.99964834134333
Free cash flow (dilution-adjusted): -8951000
Buyback yield (%): 0
Retained earnings: -396780000
Inventory turnover: 0.44019337016574583
Receivables turnover: 1.8863460475400773
Capitalized R&D asset: 9250110
ROCI (R&D-adjusted, %): -93.78813581876081
Rosenberg metric: -0.20988860660543288
FCF margin (%): -52.461610596647525
Revenue growth (%): -7.3623629058529705
Rule of 40 score: -59.82397350250049
Financial ratios for AVH.AX — quarterly report dated 2025-12-31
Total revenue: 17615000
Gross profit: 14311000
Operating income: -10408000
Net income: -11621000
Capital expenditures: 674000
Operating cash flow: -5438000
Depreciation & amortization: 700000
Net tangible assets: -22295000
Owner earnings: -11595000
Buffett classification: The Gruesome
Stock price: 0.7046979865771812
Shares outstanding: 153883445
Book value: -16650000
Market cap (USD): 108441353.8590604
Debt to equity: -2.7656456456456455
Current ratio: 0.5662364184629131
Quick ratio: 0.4557333631156565
Interest coverage ratio: -8.3264
COGS to revenue (%): 18.756741413567983
R&D to revenue (%): 32.30769230769231
SG&A to revenue (%): 108.02157252341755
Free cash flow (dilution-adjusted): -6837000
Buyback yield (%): 0
Retained earnings: -408401000
Inventory turnover: 0.4770430262777938
Receivables turnover: 1.9342264192379488
Capitalized R&D asset: 9890770
ROCI (R&D-adjusted, %): -265.38021005222186
Rosenberg metric: 0.11632870864461047
FCF margin (%): -38.813511212035195
Revenue growth (%): 3.2411206189192354
Rule of 40 score: -35.57239059311596
Financial ratios for AVH.AX — annual report dated 2025-12-31
Total revenue: 71610000
Gross profit: 58816000
Operating income: -42534000
Net income: -48587000
Capital expenditures: 1005000
Operating cash flow: -31195000
Depreciation & amortization: 2347000
Net tangible assets: -22295000
Owner earnings: -47245000
Buffett classification: The Gruesome
Stock price: 0.7046979865771812
Shares outstanding: 153883445
Book value: -16650000
Market cap (USD): 108441353.8590604
Debt to equity: -2.7656456456456455
Current ratio: 0.5662364184629131
Quick ratio: 0.4557333631156565
Interest coverage ratio: -8.5
COGS to revenue (%): 17.86621980170367
R&D to revenue (%): 29.100684261974585
SG&A to revenue (%): 112.42982823627985
Free cash flow (dilution-adjusted): -42453000
Buyback yield (%): 0
Retained earnings: -408401000
Inventory turnover: 1.8472422754836846
Receivables turnover: 7.863182167563413
Capitalized R&D asset: 41351130
ROCI (R&D-adjusted, %): -120.82409245997015
Rosenberg metric: 0.17971512770137524
FCF margin (%): -59.283619606200254
Revenue growth (%): 11.453518233179249
Rule of 40 score: -47.83010137302101
Financial ratios for BHC — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 1222047244.0944881
Buffett classification: The Gruesome
Stock price: 27.61
Shares outstanding: 373475644
Market cap (USD): 10311662530.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BHC — annual report dated 2022-12-31
Total revenue: 5973529411.764706
Gross profit: 4235294117.6470585
Operating income: 1022794117.6470587
Net income: -155882352.94117647
Capital expenditures: 160294117.6470588
Operating cash flow: -535294117.6470588
Depreciation & amortization: 1024999999.9999999
Net tangible assets: -13263970588.235292
Owner earnings: 708823529.4117645
Capex to operating income (%): 15.672178289000719
Buffett classification: The Great
Stock price: 6.28
Shares outstanding: 373475644
Book value: 191176470.58823395
P/B ratio: 12.268387616443166
Market cap (USD): 2345427044.32
Debt to equity: 79.86923076923132
Current ratio: 1.0776452676985537
Quick ratio: 0.8010657193605683
Interest coverage ratio: 0.9501366120218578
COGS to revenue (%): 29.098966026587885
R&D to revenue (%): 6.511570654849827
SG&A to revenue (%): 32.31166912850812
Free cash flow (dilution-adjusted): -824999999.9999999
Buyback yield (%): 0
Retained earnings: -6754411764.705882
Inventory turnover: 2.168807339449541
Receivables turnover: 4.5385474860335195
Capitalized R&D asset: 388970588.2352941
ROCI (R&D-adjusted, %): 7.828260153841549
FCF margin (%): -13.810930576070898
Rule of 40 score: -13.810930576070898
Financial ratios for BHC — annual report dated 2023-12-31
Total revenue: 6634090909.090909
Gross profit: 4695454545.454545
Operating income: 1212121212.121212
Net income: -448484848.48484844
Capital expenditures: 162878787.87878788
Operating cash flow: 781818181.8181818
Depreciation & amortization: 957575757.5757575
Net tangible assets: -14137121212.121212
Owner earnings: 346212121.2121212
Capex to operating income (%): 13.437500000000002
Buffett classification: The Great
Stock price: 8.02
Shares outstanding: 373475644
Book value: -62121212.121212006
Market cap (USD): 2995274664.8799996
Debt to equity: -273.02439024390293
Current ratio: 1.3007903300790329
Quick ratio: 0.9418874941887493
Interest coverage ratio: 1.2048192771084336
COGS to revenue (%): 29.22233641658102
R&D to revenue (%): 6.897339271439991
SG&A to revenue (%): 33.31049446157359
Free cash flow (dilution-adjusted): 475757575.75757575
Buyback yield (%): 0
Retained earnings: -7407575757.575757
Inventory turnover: 1.657383419689119
Receivables turnover: 4.382882882882884
Capitalized R&D asset: 718186051.6934047
ROCI (R&D-adjusted, %): 7.632602022484485
Rosenberg metric: 1.1830211376525175
FCF margin (%): 7.171405732556811
Revenue growth (%): 11.058144219148653
Rule of 40 score: 18.229549951705465
Financial ratios for BHC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.16
Shares outstanding: 373475644
Market cap (USD): 3047561255.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BHC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.06
Shares outstanding: 373475644
Market cap (USD): 3010213690.6400003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BHC — annual report dated 2024-12-31
Total revenue: 6730769230.769231
Gross profit: 4785314685.314686
Operating income: 1296503496.5034966
Net income: -32167832.16783217
Capital expenditures: 235664335.66433567
Operating cash flow: 1116783216.7832167
Depreciation & amortization: 886013986.0139861
Net tangible assets: -12529370629.37063
Owner earnings: 618181818.1818182
Capex to operating income (%): 18.176914778856528
Buffett classification: The Great
Stock price: 8.06
Shares outstanding: 373475644
Book value: -225174825.17482376
Market cap (USD): 3010213690.6400003
Debt to equity: -67.13043478260913
Current ratio: 0.855154028436019
Quick ratio: 0.6189277251184835
Effective tax rate (%): 143.11377245508982
Interest coverage ratio: 1.3357348703170029
COGS to revenue (%): 28.903896103896106
R&D to revenue (%): 6.4
SG&A to revenue (%): 34.24415584415584
Free cash flow (dilution-adjusted): 774125874.1258742
Buyback yield (%): 0
Retained earnings: -6869930069.93007
Inventory turnover: 1.7442006269592476
Receivables turnover: 4.497663551401868
Capitalized R&D asset: 865705282.4626354
ROCI (R&D-adjusted, %): 8.858821997545714
Rosenberg metric: 0.196383087111566
FCF margin (%): 11.501298701298701
Revenue growth (%): 1.4572957019000208
Rule of 40 score: 12.958594403198722
Financial ratios for BHC — quarterly report dated 2025-03-31
Total revenue: 1579720279.7202797
Gross profit: 1089510489.5104895
Operating income: 204195804.1958042
Net income: -40559440.55944056
Capital expenditures: 80419580.41958043
Operating cash flow: 147552447.55244756
Depreciation & amortization: 213286713.2867133
Net tangible assets: -12330769230.769232
Owner earnings: 92307692.30769232
Capex to operating income (%): 39.38356164383562
Buffett classification: The Good
Stock price: 6.47
Shares outstanding: 373475644
Book value: -167832167.83216858
Market cap (USD): 2416387416.68
Debt to equity: -89.6249999999996
Current ratio: 1.3468045112781954
Quick ratio: 0.9678101503759399
Interest coverage ratio: 0.8848484848484849
COGS to revenue (%): 31.031429836210716
R&D to revenue (%): 6.330234617087206
SG&A to revenue (%): 38.37981407702523
Free cash flow (dilution-adjusted): 30769230.76923077
Buyback yield (%): 0
Retained earnings: -6910489510.489511
Inventory turnover: 0.43459392436453814
Receivables turnover: 1.090250965250965
Capitalized R&D asset: 100000000
ROCI (R&D-adjusted, %): 1.736297890144044
FCF margin (%): 1.9477644975652946
Rule of 40 score: 1.9477644975652946
Financial ratios for BHC — quarterly report dated 2025-06-30
Total revenue: 1846715328.467153
Gross profit: 1289051094.8905108
Operating income: 333576642.3357664
Net income: 108029197.08029196
Capital expenditures: 72262773.72262773
Operating cash flow: 210948905.10948902
Depreciation & amortization: 224087591.2408759
Net tangible assets: -12488321167.883211
Owner earnings: 259854014.5985401
Return on net tangible assets (%): -2.080776199660997
Capex to operating income (%): 21.663019693654267
Buffett classification: The Great
Stock price: 6.66
P/E ratio: 36.86611479428253
Shares outstanding: 373475644
Book value: 107299270.07299423
P/B ratio: 23.18140456452212
Market cap (USD): 2487347789.04
Debt to equity: 147.87755102040603
Current ratio: 1.3093467336683418
Quick ratio: 0.9766834170854273
Effective tax rate (%): 8.571428571428571
Interest coverage ratio: 0.9827956989247311
COGS to revenue (%): 30.19762845849802
R&D to revenue (%): 6.284584980237154
SG&A to revenue (%): 35.33596837944664
Free cash flow (dilution-adjusted): 104379562.0437956
Buyback yield (%): 0
Retained earnings: -7105109489.051094
Inventory turnover: 0.46163141993957696
Receivables turnover: 1.1447963800904977
Capitalized R&D asset: 183058394.16058394
ROCI (R&D-adjusted, %): 2.2949966854155472
Rosenberg metric: 1.9954060538002134
FCF margin (%): 5.652173913043478
Revenue growth (%): 16.90141300168344
Rule of 40 score: 22.553586914726917
Financial ratios for BHC — quarterly report dated 2025-09-30
Total revenue: 1928776978.4172664
Gross profit: 1389208633.0935252
Operating income: 457553956.8345324
Net income: 130215827.3381295
Capital expenditures: 65467625.89928058
Operating cash flow: 291366906.47482014
Depreciation & amortization: 220143884.89208636
Net tangible assets: -12001438848.920864
Owner earnings: 284892086.33093524
Return on net tangible assets (%): -2.3738160891979376
Capex to operating income (%): 14.30817610062893
Buffett classification: The Great
Stock price: 6.45
P/E ratio: 12.18560229216513
Shares outstanding: 373475644
Book value: 256115107.9136696
P/B ratio: 9.40560642214043
Market cap (USD): 2408917903.8
Debt to equity: 59.106741573033595
Current ratio: 1.3037763404965574
Quick ratio: 0.970373461297726
Effective tax rate (%): 16.972477064220183
Interest coverage ratio: 1.5436893203883493
COGS to revenue (%): 27.974636329727716
R&D to revenue (%): 9.212980231256992
SG&A to revenue (%): 29.65311450951138
Free cash flow (dilution-adjusted): 194964028.77697843
Buyback yield (%): 0
Retained earnings: -6874100719.424461
Inventory turnover: 0.46933667083854824
Receivables turnover: 1.1092263136119156
Capitalized R&D asset: 288456965.81420994
ROCI (R&D-adjusted, %): 3.1230430205776196
Rosenberg metric: 0.8629926247681113
FCF margin (%): 10.108168593808282
Revenue growth (%): 4.443654562516016
Rule of 40 score: 14.551823156324298
Financial ratios for BHC — quarterly report dated 2025-12-31
Total revenue: 2040875912.4087589
Gross profit: 1458394160.5839415
Operating income: 605109489.0510949
Net income: -75182481.75182481
Capital expenditures: 67153284.67153284
Operating cash flow: 361313868.6131387
Depreciation & amortization: 211678832.1167883
Net tangible assets: -12020437956.204378
Owner earnings: 69343065.69343063
Capex to operating income (%): 11.097708082026536
Buffett classification: The Great
Stock price: 6.95
P/E ratio: 21.188489770075574
Shares outstanding: 373475644
Book value: 275182481.7518234
P/B ratio: 9.432488977045141
Market cap (USD): 2595655725.8
Debt to equity: 55.307692307692584
Current ratio: 1.4729665071770335
Quick ratio: 1.0832535885167465
Effective tax rate (%): 283.9285714285714
Interest coverage ratio: 2.08816120906801
COGS to revenue (%): 28.54077253218884
R&D to revenue (%): 1.8240343347639485
SG&A to revenue (%): 31.5450643776824
Free cash flow (dilution-adjusted): 232846715.32846713
Buyback yield (%): 0
Retained earnings: -7056204379.562043
Inventory turnover: 0.4898710865561694
Receivables turnover: 1.1892811569544874
Capitalized R&D asset: 194583101.40209
ROCI (R&D-adjusted, %): 3.246180867904512
Rosenberg metric: 0.38934365672744387
FCF margin (%): 11.409155937052933
Revenue growth (%): 5.811917875724528
Rule of 40 score: 17.221073812777462
Financial ratios for BHC — annual report dated 2025-12-31
Total revenue: 7493430656.934306
Gross profit: 5294160583.941606
Operating income: 1594890510.948905
Net income: 114598540.1459854
Capital expenditures: 289781021.8978102
Operating cash flow: 1021897810.218978
Depreciation & amortization: 881751824.8175182
Net tangible assets: -12020437956.204378
Owner earnings: 706569343.0656934
Return on net tangible assets (%): -5.878066553315521
Capex to operating income (%): 18.16933638443936
Buffett classification: The Great
Stock price: 6.95
P/E ratio: 22.649989454433122
Shares outstanding: 373475644
Book value: 275182481.7518234
P/B ratio: 9.432488977045141
Market cap (USD): 2595655725.8
Debt to equity: 55.307692307692584
Current ratio: 1.4729665071770335
Quick ratio: 1.0832535885167465
Effective tax rate (%): 67.30245231607628
Interest coverage ratio: 1.362219451371571
COGS to revenue (%): 29.349308396649132
R&D to revenue (%): 6.127021235145139
SG&A to revenue (%): 33.48918760958504
Free cash flow (dilution-adjusted): 567153284.6715329
Buyback yield (%): 0
Retained earnings: -7056204379.562043
Inventory turnover: 1.8496009821976673
Receivables turnover: 4.36665248830285
Capitalized R&D asset: 898739472.2066255
ROCI (R&D-adjusted, %): 9.389034245932285
Rosenberg metric: 1.1812494075267779
FCF margin (%): 7.568673290473408
Revenue growth (%): 11.330969760166832
Rule of 40 score: 18.89964305064024
Financial ratios for BMT.AX — annual report dated 2021-06-30
Total revenue: 6305296.992481203
Gross profit: 6305296.992481203
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3157894736842105
Shares outstanding: 290696163
Market cap (USD): 91798788.31578948
COGS to revenue (%): 0
Buyback yield (%): 0.4425779582295838
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMT.AX — annual report dated 2022-06-30
Total revenue: 13165517.241379311
Gross profit: 13165517.241379311
Operating income: -4237931.0344827585
Net income: -3068275.8620689656
Capital expenditures: 42068.965517241384
Depreciation & amortization: 2493793.103448276
Net tangible assets: 741379.3103448276
Owner earnings: -616551.724137931
Return on net tangible assets (%): -83.16279069767441
Buffett classification: The Gruesome
Stock price: 0.19999999999999998
Shares outstanding: 290696163
Book value: 34541379.31034483
P/B ratio: 1.6831763456124584
Market cap (USD): 58139232.599999994
Debt to equity: 0.02230208645302985
Current ratio: 1.6546004706937127
Quick ratio: 1.6546004706937127
Interest coverage ratio: -245.79999999999995
COGS to revenue (%): 0
SG&A to revenue (%): 77.08224201152436
Free cash flow (dilution-adjusted): -3328275.8620689656
Buyback yield (%): 0
Retained earnings: -1563448.275862069
Receivables turnover: 2.4680025856496446
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.87745384383906
FCF margin (%): -25.280251440544788
Revenue growth (%): 108.80090592209419
Rule of 40 score: 83.5206544815494
Financial ratios for BMT.AX — annual report dated 2023-06-30
Total revenue: 1158278.1456953643
Gross profit: 1158278.1456953643
Operating income: -18372847.682119206
Net income: -4574834.437086092
Capital expenditures: 77483.44370860927
Depreciation & amortization: 3240397.3509933776
Net tangible assets: 1019867.5496688741
Owner earnings: -1411920.529801324
Return on net tangible assets (%): -138.4415584415584
Buffett classification: The Gruesome
Stock price: 0.152317880794702
Shares outstanding: 290696163
Book value: 31272185.430463575
P/B ratio: 1.4158979583236273
Market cap (USD): 44278223.50331126
Debt to equity: 0.01598864911797717
Current ratio: 1.1808519336113155
Quick ratio: 1.1808519336113155
Interest coverage ratio: -815.9705882352941
COGS to revenue (%): 0
SG&A to revenue (%): 1153.5734705546026
Free cash flow (dilution-adjusted): -1247019.8675496688
Buyback yield (%): 0
Retained earnings: -6076158.940397351
Receivables turnover: 0.38254593175853024
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -55.15835934548781
FCF margin (%): -107.66152086906801
Revenue growth (%): -91.2021827592547
Rule of 40 score: -198.8637036283227
Financial ratios for BMT.AX — annual report dated 2024-06-30
Operating income: -22612666.666666668
Net income: -3404000
Capital expenditures: 44666.666666666664
Depreciation & amortization: 3628000
Net tangible assets: 1636666.6666666667
Owner earnings: 179333.33333333334
Buffett classification: The Gruesome
Stock price: 0.15333333333333335
Shares outstanding: 290696163
Book value: 31423999.999999996
P/B ratio: 1.4184512366344197
Market cap (USD): 44573411.660000004
Debt to equity: 0.03521724372029872
Current ratio: 1.279431363838294
Quick ratio: 1.279431363838294
Interest coverage ratio: -1356.76
Free cash flow (dilution-adjusted): -3009333.3333333335
Buyback yield (%): 0
Retained earnings: -9250000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -66.96874568105984
Rule of 40 score: 0
Financial ratios for CLSK — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.59
Shares outstanding: 256608606
Market cap (USD): 2974093743.54
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLSK — annual report dated 2022-09-30
Total revenue: 131525000
Gross profit: 49371000
Operating income: -16566000
Net income: -57326000
Capital expenditures: 186969000
Operating cash flow: 73458000
Depreciation & amortization: 49045000
Net tangible assets: 397527000
Owner earnings: -195250000
Return on net tangible assets (%): -49.11616066330085
Buffett classification: The Gruesome
Stock price: 3.18
Shares outstanding: 256608606
Book value: 404012000
P/B ratio: 2.0197800240586914
Market cap (USD): 816015367.08
Debt to equity: 0.05499589121115214
Current ratio: 1.4916130548456272
Quick ratio: 1.4852677653417936
Interest coverage ratio: -15.36734693877551
COGS to revenue (%): 62.46264968637141
SG&A to revenue (%): 12.843185706139518
Free cash flow (dilution-adjusted): -148700000
Buyback yield (%): 0
Retained earnings: -196054000
Inventory turnover: 380.3425925925926
Receivables turnover: 4871.2962962962965
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.9576285763430996
FCF margin (%): -113.0583539251093
Rule of 40 score: -113.0583539251093
Financial ratios for CLSK — annual report dated 2023-09-30
Total revenue: 168408000
Gross profit: 29114000
Operating income: -123306000
Net income: -138148000
Capital expenditures: 300876000
Operating cash flow: -17247000
Depreciation & amortization: 120728000
Net tangible assets: 663022000
Owner earnings: -318296000
Return on net tangible assets (%): -48.00685346790906
Buffett classification: The Gruesome
Stock price: 3.81
Shares outstanding: 256608606
Book value: 675668000
P/B ratio: 1.4469810452174738
Market cap (USD): 977678788.86
Debt to equity: 0.024318156254255048
Current ratio: 1.3796772668962258
Quick ratio: 1.3687529538856256
Interest coverage ratio: -41.41954988243198
COGS to revenue (%): 82.71222269725904
SG&A to revenue (%): 18.818583440216617
Free cash flow (dilution-adjusted): -342265000
Buyback yield (%): 0
Retained earnings: -334202000
Inventory turnover: 172.1804697156984
Receivables turnover: 17.560792492179353
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.934818180628138
FCF margin (%): -203.23559450857442
Revenue growth (%): 28.04257745675727
Rule of 40 score: -175.19301705181715
Financial ratios for CLSK — annual report dated 2024-09-30
Total revenue: 378968000
Gross profit: 139357000
Operating income: -59243000
Net income: -145777000
Capital expenditures: 806396000
Operating cash flow: -233662000
Depreciation & amortization: 154609000
Net tangible assets: 1749758000
Owner earnings: -797564000
Return on net tangible assets (%): -45.58138896921746
Buffett classification: The Gruesome
Stock price: 9.34
Shares outstanding: 256608606
Book value: 1760841000
P/B ratio: 1.3611248148129218
Market cap (USD): 2396724380.04
Debt to equity: 0.038023876091026955
Current ratio: 3.754543954611016
Quick ratio: 3.754543954611016
Interest coverage ratio: -24.131568228105905
COGS to revenue (%): 63.22723818369889
SG&A to revenue (%): 11.608104114331553
Free cash flow (dilution-adjusted): -1069613000
Buyback yield (%): 0
Retained earnings: -479218000
Receivables turnover: 2.7313796433771063
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.338056936794805
FCF margin (%): -282.24361951404865
Revenue growth (%): 125.02968980095956
Rule of 40 score: -157.2139297130891
Financial ratios for CLSK — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.34
Shares outstanding: 256608606
Market cap (USD): 2396724380.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLSK — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.21
Shares outstanding: 256608606
Market cap (USD): 2363365261.26
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLSK — quarterly report dated 2025-03-31
Total revenue: 181712000
Gross profit: 81033000
Operating income: -12587000
Net income: -138792000
Capital expenditures: 34092000
Operating cash flow: -112283000
Depreciation & amortization: 78901000
Net tangible assets: 1751297000
Owner earnings: -93983000
Return on net tangible assets (%): -5.366479814674496
Buffett classification: The Gruesome
Stock price: 6.72
Shares outstanding: 256608606
Book value: 1890491000
P/B ratio: 0.9121491889249935
Market cap (USD): 1724409832.32
Debt to equity: 0.3423237666828353
Current ratio: 8.667785787470725
Quick ratio: 8.667785787470725
Interest coverage ratio: -9.9344909234412
COGS to revenue (%): 55.405806991282915
SG&A to revenue (%): 8.100180505415162
Free cash flow (dilution-adjusted): -149476000
Buyback yield (%): 0
Retained earnings: -376360000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.4940561748975345
FCF margin (%): -82.2598397464119
Rule of 40 score: -82.2598397464119
Financial ratios for CLSK — quarterly report dated 2025-06-30
Total revenue: 198644000
Gross profit: 92118000
Operating income: -22332000
Net income: 257390000
Capital expenditures: 41124000
Operating cash flow: -109888000
Depreciation & amortization: 94880000
Net tangible assets: 2011123000
Owner earnings: 311146000
Return on net tangible assets (%): 15.471256606383598
Buffett classification: The Gruesome
Stock price: 11.03
P/E ratio: 23.865435540059696
Shares outstanding: 256608606
Book value: 2146888000
P/B ratio: 1.3183700892547723
Market cap (USD): 2830392924.18
Debt to equity: 0.3821051680385749
Current ratio: 4.371592990365546
Quick ratio: 4.371592990365546
Effective tax rate (%): 6.572485362817019
Interest coverage ratio: -6.465547191661841
COGS to revenue (%): 53.62658826846016
SG&A to revenue (%): 9.85179517126115
Free cash flow (dilution-adjusted): -156910000
Buyback yield (%): 0
Retained earnings: -124573000
Receivables turnover: 0.7316780298426099
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7905138339920948
FCF margin (%): -78.99055596947304
Revenue growth (%): 9.318041736374044
Rule of 40 score: -69.672514233099